{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:25:31Z","timestamp":1791588331583,"version":"4.3.4"},"reference-count":180,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009395","name":"CancerCare Manitoba Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009395","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Health","award":["R21 AI121822"],"award-info":[{"award-number":["R21 AI121822"]}]},{"name":"National Institute of Health","award":["R21 CA271069"],"award-info":[{"award-number":["R21 CA271069"]}]},{"name":"National Institute of Health","award":["R21 CA274265"],"award-info":[{"award-number":["R21 CA274265"]}]},{"name":"Jake Gittlen\u2019s Laboratories for Cancer Research, and the Pathology Department Research Initiative"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"crossref","award":["MOT-163034"],"award-info":[{"award-number":["MOT-163034"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"publisher","award":["PJT-197796"],"award-info":[{"award-number":["PJT-197796"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"publisher","award":["BH6-198724"],"award-info":[{"award-number":["BH6-198724"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Human papillomavirus (HPV), especially high-risk HPV types, is a significant public health concern due to its association with various cancers and increased risk of acquiring other sexually transmitted infections (STIs). In most cases, host immunity rapidly responds to and clears HPV infections, but persistent or latent infections can increase susceptibility to cancer. A better understanding of how HPV interacts with and evades the immune response is vital to understanding disease progression and guiding the next generation of vaccines and immunotherapies. This review article provides a comprehensive overview of the immune mechanisms involved in HPV infection, highlighting the roles of T cells and other immune subsets. We discuss the immune evasion strategies employed by HPV and subsequent modulation of the immune microenvironment. Additionally, we explore the current therapeutic landscape and emerging immunotherapeutic approaches under investigation. By unveiling the intricacies of the immune response to HPV, we may inform improved strategies for the treatment of HPV-related diseases.<\/jats:p>","DOI":"10.3390\/v18030362","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:13:14Z","timestamp":1773659594000},"page":"362","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cell-Mediated Immunity Against Human Papillomavirus Infection: From Viral Clearance to Oncogenesis"],"prefix":"10.3390","volume":"18","author":[{"given":"Diana","family":"Savage","sequence":"first","affiliation":[{"name":"Department of Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0T5, Canada"},{"name":"Paul Albrechtsen Research Institute, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8700-9937","authenticated-orcid":false,"given":"Jiafen","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D.","family":"Burgener","sequence":"additional","affiliation":[{"name":"Center for Global Health and Diseases, Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Raouf","sequence":"additional","affiliation":[{"name":"Department of Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0T5, Canada"},{"name":"Paul Albrechtsen Research Institute, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3030-2726","authenticated-orcid":false,"given":"Thomas T.","family":"Murooka","sequence":"additional","affiliation":[{"name":"Department of Immunology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0T5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/jamaoncol.2015.5504","article-title":"Associations of oral \u03b1-, \u03b2-, and \u03b3-human papillomavirus types with risk of incident head and neck cancer","volume":"2","author":"Agalliu","year":"2016","journal-title":"JAMA Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jamadermatol.2015.4530","article-title":"Association between \u03b2-genus human papillomavirus and cutaneous squamous cell carcinoma in immunocompetent individuals-a meta-analysis","volume":"152","author":"Chahoud","year":"2016","journal-title":"JAMA Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.virol.2015.02.004","article-title":"Beta genus papillomaviruses and skin cancer","volume":"479\u2013480","author":"Howley","year":"2015","journal-title":"Virology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5701639","DOI":"10.1155\/2020\/5701639","article-title":"The Role of Beta HPV Types and HPV-Associated Inflammatory Processes in Cutaneous Squamous Cell Carcinoma","volume":"2020","author":"Tampa","year":"2020","journal-title":"J. Immunol. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.virusres.2016.12.017","article-title":"The low-risk papillomaviruses","volume":"231","author":"Egawa","year":"2017","journal-title":"Virus Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/rmv.488","article-title":"Human papillomaviruses: Basic mechanisms of pathogenesis and oncogenicity","volume":"16","author":"Hebner","year":"2006","journal-title":"Rev. Med. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41579-021-00617-5","article-title":"Human papillomaviruses: Diversity, infection and host interactions","volume":"20","author":"McBride","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Yu, L., Majerciak, V., and Zheng, Z.M. (2022). HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23094943"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex. Transm. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ygyno.2010.01.024","article-title":"Pathology and epidemiology of HPV infection in females","volume":"117","author":"Stanley","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jiph.2023.02.014","article-title":"Human papillomavirus in cancer: Infection, disease transmission, and progress in vaccines","volume":"16","author":"Oyouni","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ygyno.2008.07.045","article-title":"Natural history and epidemiology of HPV infection and cervical cancer","volume":"110","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/oxfordjournals.jncimonographs.a003477","article-title":"Chapter 3: Cofactors in human papillomavirus carcinogenesis\u2014Role of parity, oral contraceptives, and tobacco smoking","volume":"2003","year":"2003","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-1702(02)00188-0","article-title":"Environmental co-factors in HPV carcinogenesis","volume":"89","author":"Bosch","year":"2002","journal-title":"Virus Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kombe, A.J.K., Li, B., Zahid, A., Mengist, H.M., Bounda, G.A., Zhou, Y., and Jin, T. (2021). Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front. Public Health, 8.","DOI":"10.3389\/fpubh.2020.552028"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Zayats, R., Murooka, T.T., and McKinnon, L.R. (2022). HPV and the Risk of HIV Acquisition in Women. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.814948"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ygyno.2010.04.004","article-title":"Current understanding of the mechanism of HPV infection","volume":"118","author":"Schiller","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4161\/cc.5.14.3094","article-title":"Partitioning viral genomes in mitosis: Same idea, different targets","volume":"5","author":"McBride","year":"2006","journal-title":"Cell Cycle"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e29361","DOI":"10.1002\/jmv.29461","article-title":"The human papillomavirus late life cycle and links to keratinocyte differentiation","volume":"96","author":"Kirk","year":"2024","journal-title":"J. Med. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"110387","DOI":"10.1016\/j.virol.2024.110387","article-title":"The functions of papillomavirus E2 proteins","volume":"603","author":"Morgan","year":"2025","journal-title":"Virology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1128\/JVI.06450-11","article-title":"The E1 Protein of Human Papillomavirus Type 16 Is Dispensable for Maintenance Replication of the Viral Genome","volume":"86","author":"Egawa","year":"2012","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: From basic studies to clinical application","volume":"2","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e00713-17","DOI":"10.1128\/mBio.00713-17","article-title":"Viral DNA replication orientation and hnRNPs regulate transcription of the human papillomavirus 18 late promoter","volume":"8","author":"Wang","year":"2017","journal-title":"mBio"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Borgogna, C., Olivero, C., Lanfredini, S., Calati, F., De Andrea, M., Zavattaro, E., Savoia, P., Trisolini, E., Boldorini, R., and Patel, G.K. (2018). \u03b2-HPV infection correlates with early stages of carcinogenesis in skin tumors and patient-derived xenografts from a kidney transplant recipient cohort. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00117"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Viarisio, D., M\u00fcller-Decker, K., Accardi, R., Robitaille, A., D\u00fcrst, M., Beer, K., Jansen, L., Flechtenmacher, C., Bozza, M., and Harbottle, R. (2018). Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1006783"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41586-019-1719-9","article-title":"Immunity to commensal papillomaviruses protects against skin cancer","volume":"575","author":"Strickley","year":"2019","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Skelin, J., and Tomai\u0107, V. (2023). Comparative Analysis of Alpha and Beta HPV E6 Oncoproteins: Insights into Functional Distinctions and Divergent Mechanisms of Pathogenesis. Viruses, 15.","DOI":"10.3390\/v15112253"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/1346-8138.16697","article-title":"Recent advances in cutaneous HPV infection","volume":"50","author":"Shimizu","year":"2023","journal-title":"J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1128\/JVI.06243-11","article-title":"High-Risk Human Papillomavirus E5 Oncoprotein Displays Channel-Forming Activity Sensitive to Small-Molecule Inhibitors","volume":"86","author":"Wetherill","year":"2012","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Gheit, T. (2019). Mucosal and cutaneous human papillomavirus infections and cancer biology. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00355"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2019.12.002","article-title":"The human papillomavirus 16 E5 gene potentiates MmuPV1-Dependent pathogenesis","volume":"541","author":"Torres","year":"2020","journal-title":"Virology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/scbi.1999.0141","article-title":"Human papillomavirus life cycle: Active and latent phases","volume":"9","author":"Stubenrauch","year":"1999","journal-title":"Semin. Cancer Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-9378-5-19","article-title":"HPV\u2014Immune response to infection and vaccination","volume":"5","author":"Stanley","year":"2010","journal-title":"Infect. Agents Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/171.4.1026","article-title":"Human Papillomavirus Infection Is Transient in Young Women: A Population-Based Cohort Study","volume":"171","author":"Evander","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1086\/315086","article-title":"Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer","volume":"180","author":"Franco","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Alizon, S., Murall, C.L., and Bravo, I.G. (2017). Why human papillomavirus acute infections matter. Viruses, 9.","DOI":"10.1101\/144576"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/ajt.14181","article-title":"Reactivation of Latent HPV Infections After Renal Transplantation","volume":"17","author":"Hinten","year":"2017","journal-title":"Am. J. Transplant."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1470-2045(01)00617-9","article-title":"Persistent human papillomavirus infection and cervical neoplasia","volume":"3","author":"Ferenczy","year":"2002","journal-title":"Lancet Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kiamba, E.W., Goodier, M.R., and Clarke, E. (2025). Immune responses to human papillomavirus infection and vaccination. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1591297"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"Nestle","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.celrep.2020.01.003","article-title":"Cell Lineage Tracing Identifies Hormone-Regulated and Wnt-Responsive Vaginal Epithelial Stem Cells","volume":"30","author":"Ali","year":"2020","journal-title":"Cell Rep."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"de Szalay, S., and Wertz, P.W. (2023). Protective Barriers Provided by the Epidermis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043145"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/oxfordjournals.jncimonographs.a003443","article-title":"Biology of Oral Mucosa and Esophagus","volume":"2001","author":"Squier","year":"2001","journal-title":"JNCI Monogr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/aji.12230","article-title":"The Structure of the Human Vaginal Stratum Corneum and its Role in Immune Defense","volume":"71","author":"Anderson","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: Functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Moody, C.A. (2017). Mechanisms by which HPV induces a replication competent environment in differentiating keratinocytes. Viruses, 9.","DOI":"10.3390\/v9090261"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0046-8177(92)90232-R","article-title":"Human Papillomavirus Type 16 and 18 Gene Expression in Cervical Neoplasias","volume":"23","author":"Stoler","year":"1992","journal-title":"Hum. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1101\/gad.12.13.2061","article-title":"Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity","volume":"12","author":"Ronco","year":"1998","journal-title":"Genes Dev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9486","DOI":"10.1128\/JVI.05007-11","article-title":"Suppression of STAT-1 Expression by Human Papillomaviruses Is Necessary for Differentiation-Dependent Genome Amplification and Plasmid Maintenance","volume":"85","author":"Hong","year":"2011","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1158\/1078-0432.CCR-24-0385","article-title":"Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF","volume":"30","author":"Arias","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1074\/jbc.274.9.5810","article-title":"The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes","volume":"274","author":"Joyce","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1743-422X-5-118","article-title":"Cutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropism","volume":"5","author":"Mistry","year":"2008","journal-title":"Virol. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1574-6968.2001.tb10883.x","article-title":"Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate","volume":"204","author":"Combita","year":"2001","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1128\/JVI.75.3.1565-1570.2001","article-title":"Human Papillomavirus Infection Requires Cell Surface Heparan Sulfate","volume":"75","author":"Giroglou","year":"2001","journal-title":"J. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0042-6822(03)00114-4","article-title":"Carboxy-fluorescein diacetate, succinimidyl ester labeled papillomavirus virus-like particles fluoresce after internalization and interact with heparan sulfate for binding and entry","volume":"310","author":"Drobni","year":"2003","journal-title":"Virology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00192-004-1150-z","article-title":"Sulfated glycosaminoglycans of the vagina and perineal skin in pre- and postmenopausal women, according to genital prolapse stage","volume":"15","author":"Bezerra","year":"2004","journal-title":"Int. Urogynecol. J."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Clayton, K., Vallejo, A.F., Davies, J., Sirvent, S., and Polak, M.E. (2017). Langerhans cells-programmed by the epidermis. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01676"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13073-014-0098-y","article-title":"Transcriptional fingerprints of antigen-presenting cell subsets in the human vaginal mucosa and skin reflect tissue-specific immune microenvironments","volume":"6","author":"Duluc","year":"2014","journal-title":"Genome Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/icb.2010.42","article-title":"Viruses and Langerhans cells","volume":"88","author":"Cunningham","year":"2010","journal-title":"Immunol. Cell Biol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Otsuka, M., Egawa, G., and Kabashima, K. (2018). Uncovering the Mysteries of Langerhans Cells, Inflammatory Dendritic Epidermal Cells, and Monocyte-Derived Langerhans Cell-Like Cells in the Epidermis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01768"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Dai, W., Gui, L., Du, H., Li, S., and Wu, R. (2022). The association of cervicovaginal Langerhans cells with clearance of human papillomavirus. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.918190"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"103326","DOI":"10.1016\/j.isci.2021.103326","article-title":"A model of impaired Langerhans cell maturation associated with HPV induced epithelial hyperplasia","volume":"24","author":"Tuong","year":"2021","journal-title":"iScience"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Deckers, J., Hammad, H., and Hoste, E. (2018). Langerhans cells: Sensing the environment in health and disease. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00093"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41586-020-2931-3","article-title":"Defining HPV-specific B cell responses in patients with head and neck cancer","volume":"597","author":"Wieland","year":"2021","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s40425-019-0726-6","article-title":"Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8+ T cells","volume":"7","author":"Laco","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Prabhu, P.R., Carter, J.J., and Galloway, D.A. (2022). B Cell Responses upon Human Papillomavirus (HPV) Infection and Vaccination. Vaccines, 10.","DOI":"10.3390\/vaccines10060837"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3892\/ol.2015.2884","article-title":"Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review)","volume":"9","author":"Fernandes","year":"2015","journal-title":"Oncol. Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.4049\/jimmunol.1002756","article-title":"Human Papillomavirus 16-Associated Cervical Intraepithelial Neoplasia in Humans Excludes CD8 T Cells from Dysplastic Epithelium","volume":"185","author":"Trimble","year":"2010","journal-title":"J. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/bjc.2015.277","article-title":"Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma","volume":"113","author":"Oguejiofor","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ejca.2015.04.024","article-title":"A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancer","volume":"51","author":"Tertipis","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41598-019-57111-5","article-title":"CD8 infiltration is associated with disease control and tobacco exposure in intermediate-risk oropharyngeal cancer","volume":"10","author":"Kemnade","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1007\/s00262-023-03571-8","article-title":"HPV-associated head and neck cancer is characterized by distinct profiles of CD8+ T cells and myeloid-derived suppressor cells","volume":"72","author":"Kansy","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Shen, X., Wang, C., Li, M., Wang, S., Zhao, Y., Liu, Z., and Zhu, G. (2022). Identification of CD8+ T cell infiltration-related genes and their prognostic values in cervical cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1031643"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.omto.2021.07.006","article-title":"Prognostic and therapeutic TILs of cervical cancer\u2014Current advances and future perspectives","volume":"22","author":"Tang","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.2147\/CMAR.S217264","article-title":"Infiltrating CD4 and CD8 lymphocytes in hpv infected uterine cervical milieu","volume":"11","author":"Maskey","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1158\/1078-0432.CCR-07-4554","article-title":"Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+\/regulatory T-cell ratio: Which variable determines survival of cervical cancer patients?","volume":"14","author":"Jordanova","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/jnci\/89.17.1285","article-title":"Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7\u2014Outcome of HPV infection and associated neoplasia","volume":"89","author":"Kadish","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1099\/vir.0.82678-0","article-title":"Resolution of cervical dysplasia is associated with T-cell proliferative responses to human papillomavirus type 16 E2","volume":"88","author":"Dillon","year":"2007","journal-title":"J. Gen. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00262-011-1092-5","article-title":"CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend","volume":"61","author":"Kim","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Swase, T.D., Fasogbon, I.V., Eseoghene, I.J., Etukudo, E.M., Mbina, S.A., Joan, C., Dangana, R.S., Anyanwu, C., Vandu, C.D., and Agbaje, A.B. (2025). The impact of HPV\/HIV co-infection on immunosuppression, HPV genotype, and cervical cancer biomarkers. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-13516-2"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Cenerenti, M., Saillard, M., Romero, P., and Jandus, C. (2022). The Era of Cytotoxic CD4 T Cells. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.867189"},{"key":"ref_82","first-page":"954602","article-title":"Cytotoxic CD4 T cells in antiviral immunity","volume":"2011","author":"Marshall","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1586\/erv.10.132","article-title":"Cytolytic CD4+ T cells in viral immunity","volume":"9","author":"Soghoian","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s42003-023-04812-3","article-title":"Human CD4 cytotoxic T lymphocytes mediate potent tumor control in humanized immune system mice","volume":"6","author":"Lin","year":"2023","journal-title":"Commun. Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/eji.200425699","article-title":"CD4+ T cell immunity against the human papillomavirus-18 E6 transforming protein in healthy donors: Identification of promiscuous naturally processed epitopes","volume":"35","author":"Facchinetti","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1016\/j.cell.2021.06.004","article-title":"Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy","volume":"184","author":"Rapaport","year":"2021","journal-title":"Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2021.09.002","article-title":"Human genetic and immunological dissection of papillomavirus-driven diseases: New insights into their pathogenesis","volume":"51","author":"Casanova","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/path.4656","article-title":"Model systems of human papillomavirus-associated disease","volume":"238","author":"Doorbar","year":"2016","journal-title":"J. Pathol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Cladel, N.M., Xu, J., Peng, X., Jiang, P., Christensen, N.D., Zheng, Z.M., and Hu, J. (2022). Modeling HPV-Associated Disease and Cancer Using the Cottontail Rabbit Papillomavirus. Viruses, 14.","DOI":"10.3390\/v14091964"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.virusres.2016.12.004","article-title":"Recent advances in preclinical model systems for papillomaviruses","volume":"231","author":"Christensen","year":"2017","journal-title":"Virus Res."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Hu, J., Cladel, N.M., Budgeon, L.R., Balogh, K.K., and Christensen, N.D. (2017). The mouse papillomavirus infection model. Viruses, 9.","DOI":"10.3390\/v9090246"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/viro.2000.0789","article-title":"Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes","volume":"283","author":"Nicholls","year":"2001","journal-title":"Virology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.cell.2024.04.009","article-title":"FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice","volume":"187","author":"Momenilandi","year":"2024","journal-title":"Cell"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Wang, J.W., Jiang, R., Peng, S., Chang, Y.N., Hung, C.F., and Roden, R.B.S. (2015). Immunologic Control of Mus musculus Papillomavirus Type 1. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005243"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e00699-17","DOI":"10.1128\/JVI.00699-17","article-title":"Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection","volume":"91","author":"Jiang","year":"2017","journal-title":"J. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e00087-20","DOI":"10.1128\/JVI.00087-20","article-title":"Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice","volume":"94","author":"Scagnolari","year":"2020","journal-title":"J. Virol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"16932","DOI":"10.1038\/s41598-017-17089-4","article-title":"Mouse papillomavirus infection persists in mucosal tissues of an immunocompetent mouse strain and progresses to cancer","volume":"7","author":"Cladel","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Brendle, S.A., Li, J.J., Walter, V., Schell, T.D., Kozak, M., Balogh, K.K., Lu, S., Christensen, N.D., Zhu, Y., and El-Bayoumy, K. (2023). Immune Responses in Oral Papillomavirus Clearance in the MmuPV1 Mouse Model. Pathogens, 12.","DOI":"10.3390\/pathogens12121452"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Handisurya, A., Day, P.M., Thompson, C.D., Bonelli, M., Lowy, D.R., and Schiller, J.T. (2014). Strain-Specific Properties and T Cells Regulate the Susceptibility to Papilloma Induction by Mus musculus Papillomavirus 1. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004314"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"9777","DOI":"10.1158\/0008-5472.CAN-10-0352","article-title":"Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma","volume":"70","author":"Neale","year":"2010","journal-title":"Cancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"11636","DOI":"10.1128\/JVI.74.24.11636-11641.2000","article-title":"The Ubiquity and Impressive Genomic Diversity of Human Skin Papillomaviruses Suggest a Commensalic Nature of These Viruses","volume":"74","author":"Antonsson","year":"2000","journal-title":"J. Virol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1099\/vir.0.010017-0","article-title":"Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma","volume":"90","author":"Weissenborn","year":"2009","journal-title":"J. Gen. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Guennoun, R., Alyakin, A., Higuchi, H., and Demehri, S. (2024). Commensal HPVs Have Evolved to Be More Immunogenic Compared with High-Risk \u03b1-HPVs. Vaccines, 12.","DOI":"10.3390\/vaccines12070749"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Tay, S.H., and Oh, C.C. (2024). T Cell Immunity in Human Papillomavirus-Related Cutaneous Squamous Cell Carcinoma\u2014A Systematic Review. Diagnostics, 14.","DOI":"10.3390\/diagnostics14050473"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/ajt.16358","article-title":"Mus musculus papillomavirus 1 is a key driver of skin cancer development upon immunosuppression","volume":"21","author":"Dorfer","year":"2021","journal-title":"Am. J. Transplant."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jid.2022.10.023","article-title":"Enhanced Spontaneous Skin Tumorigenesis and Aberrant Inflammatory Response to UVB Exposure in Immunosuppressed Human Papillomavirus Type 8\u2014Transgenic Mice","volume":"143","author":"Borgogna","year":"2023","journal-title":"J. Investig. Dermatol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"100163","DOI":"10.1016\/j.xjidi.2022.100163","article-title":"Compromised T Cell Immunity Links Increased Cutaneous Papillomavirus Activity to Squamous Cell Carcinoma Risk","volume":"3","author":"Johnson","year":"2023","journal-title":"JID Innov."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/infdis\/jix245","article-title":"Prevalence and Concordance of Cutaneous Beta Human Papillomavirus Infection at Mucosal and Cutaneous Sites","volume":"216","author":"Hampras","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0092-8674(90)90188-K","article-title":"TGF-\u03b21 Inhibition of c-myc Transcription and Growth in Keratinocytes Is Abrogated by Viral Transforming Proteins with pRB Binding Domains","volume":"61","author":"Pietenpol","year":"1990","journal-title":"Cell"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"38557","DOI":"10.1074\/jbc.M206786200","article-title":"The human papilloma virus E7 oncoprotein inhibits transforming growth factor-\u03b2 signaling by blocking binding of the Smad complex to its target sequence","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-4598-12-38","article-title":"Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway","volume":"12","author":"French","year":"2013","journal-title":"Mol. Cancer"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41698-024-00637-3","article-title":"Cellular heterogeneity and key subsets of tissue-resident memory T cells in cervical cancer","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"ref_113","first-page":"e149950","article-title":"Distinct populations of antigen-specific tissue-resident CD8+ T cells in human cervix mucosa","volume":"6","author":"Peng","year":"2021","journal-title":"JCI Insight"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e1338230","DOI":"10.1080\/2162402X.2017.1338230","article-title":"CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer","volume":"6","author":"Komdeur","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Qi, S.Y., Yang, M.M., Li, C.Y., Yu, K., and Deng, S.L. (2024). The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1407649"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1084\/jem.20122394","article-title":"The Human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter","volume":"210","author":"Hasan","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1074\/jbc.M110.199190","article-title":"Identification of key amino acid residues that determine the ability of high risk HPV16-E7 to dysregulate major histocompatibility complex class I expression","volume":"286","author":"Heller","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1476-4598-10-140","article-title":"Papillomavirus E5: The smallest oncoprotein with many functions","volume":"10","author":"Venuti","year":"2011","journal-title":"Mol. Cancer"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Jain, M., Yadav, D., Jarouliya, U., Chavda, V., Yadav, A.K., Chaurasia, B., and Song, M. (2023). Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis. Pathogens, 12.","DOI":"10.3390\/pathogens12121380"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Mart\u00edn-Villa, J.M., Vaquero-Yuste, C., Molina-Alejandre, M., Juarez, I., Su\u00e1rez-Trujillo, F., L\u00f3pez-Nares, A., Palacio-Gruber, J., Barrera-Guti\u00e9rrez, L., Fern\u00e1ndez-Cruz, E., and Rodr\u00edguez-Sainz, C. (2022). HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.796054"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1182\/blood-2006-11-057125","article-title":"HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation","volume":"110","author":"Feger","year":"2007","journal-title":"Blood"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.4049\/jimmunol.1300438","article-title":"Binding of HLA-G to ITIM-Bearing Ig-like Transcript 2 Receptor Suppresses B Cell Responses","volume":"192","author":"Naji","year":"2014","journal-title":"J. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.4049\/jimmunol.176.3.1331","article-title":"Soluble HLA-G Inhibits Cell Cycle Progression in Human Alloreactive T Lymphocytes","volume":"176","author":"Bahri","year":"2006","journal-title":"J. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/intimm\/11.8.1351","article-title":"HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes","volume":"11","author":"Riteau","year":"1999","journal-title":"Int. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Contini, P., Murdaca, G., Puppo, F., and Negrini, S. (2020). HLA-G Expressing Immune Cells in Immune Mediated Diseases. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01613"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.humimm.2011.01.010","article-title":"Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence","volume":"72","author":"Ferguson","year":"2011","journal-title":"Hum. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12967-024-04938-w","article-title":"Harnessing the potential of HLA-G in cancer therapy: Advances, challenges, and prospects","volume":"22","author":"Wang","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Chetty-Sebastian, D., and Assounga, A.G. (2023). Regulatory T cell frequency in peripheral blood of women with advanced cervical Cancer including women living with HIV. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-11345-9"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2007.03468.x","article-title":"Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia","volume":"150","author":"Visser","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/ni1536","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells","volume":"8","author":"Pandiyan","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 Control over Foxp3+ Regulatory T Cell Function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1073\/pnas.0408197102","article-title":"Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-\u03b2 signals in vivo","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2006.04.015","article-title":"Regulatory T Cells Reversibly Suppress Cytotoxic T Cell Function Independent of Effector Differentiation","volume":"25","author":"Mempel","year":"2006","journal-title":"Immunity"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1084\/jem.20080308","article-title":"CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-\u03b2-dependent manner","volume":"205","author":"Andersson","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coi.2014.12.009","article-title":"Suppression of antigen presentation by IL-10","volume":"34","author":"Mittal","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.chom.2010.11.006","article-title":"A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: Clues to understanding HPV-pathogenesis in WHIM syndrome","volume":"8","author":"Chow","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/j.bbadis.2015.08.011","article-title":"Activated STING enhances Tregs infiltration in the HPV-related carcinogenesis of tongue squamous cells via the c-jun\/CCL22 signal","volume":"1852","author":"Liang","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/2326-6066.CIR-14-0149","article-title":"High and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer","volume":"3","author":"Heeren","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.2147\/OTT.S264312","article-title":"Cervical cancer: Emerging immune landscape and treatment","volume":"13","author":"Guo","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Gravitt, P.E., and Winer, R.L. (2017). Natural history of HPV infection across the lifespan: Role of viral latency. Viruses, 9.","DOI":"10.3390\/v9100267"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/infdis\/jiv753","article-title":"Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis","volume":"213","author":"Beachler","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Garcia-Mouronte, E., Berna-Rico, E., de Nicolas-Ruanes, B., Azcarraga-Llobet, C., Alonso-Martinez de Salinas, L., and Bea-Ardebol, S. (2023). Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241310835"},{"key":"ref_143","unstructured":"Public Health Agency of Canada (2024). Human Papillomavirus (HPV)."},{"key":"ref_144","first-page":"608","article-title":"Combination Therapies for HPV-Associated Malignancies","volume":"12","author":"Rumfiled","year":"2021","journal-title":"J. Clin. Cell. Immunol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1586\/14760584.2014.963561","article-title":"The next generation of HPV vaccines: Nonavalent vaccine V503 on the horizon","volume":"13","author":"Chatterjee","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women","volume":"372","author":"Joura","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0140-6736(17)31821-4","article-title":"Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16\u201326 years: A randomised, double-blind trial","volume":"390","author":"Huh","year":"2017","journal-title":"Lancet"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Lehtinen","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"key":"ref_150","unstructured":"Meites, E., Gee, J., Unger, E., and Markowitz, L. (2021). Chapter 11: Human Papillomavirus, Epidemiology and Prevention of Vaccine-Preventable Diseases."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1016\/j.vaccine.2017.11.089","article-title":"Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development","volume":"36","author":"Pinto","year":"2018","journal-title":"Vaccine"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/21645515.2017.1407896","article-title":"Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection","volume":"14","author":"Toft","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Pasmans, H., Berkowska, M.A., Diks, A.M., de Mooij, B., Groenland, R.J., de Rond, L., Nicolaie, M.A., van der Burg, S.H., van Dongen, J.J.M., and van der Klis, F.R.M. (2022). Characterization of the early cellular immune response induced by HPV vaccines. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.863164"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ymthe.2020.11.002","article-title":"First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers","volume":"29","author":"Komdeur","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1158\/1078-0432.CCR-24-1662","article-title":"Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial","volume":"31","author":"Eerkens","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"e069616","DOI":"10.1136\/bmjopen-2022-069616","article-title":"Efficacy and safety of therapeutic HPV vaccines to treat CIN 2\/CIN 3 lesions: A systematic review and meta-analysis of phase II\/III clinical trials","volume":"13","author":"Zhang","year":"2023","journal-title":"BMJ Open"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Zheng, Q., He, M., Mao, Z., Huang, Y., Li, X., Long, L., Guo, M., and Zou, D. (2025). Advancing the Fight Against Cervical Cancer: The Promise of Therapeutic HPV Vaccines. Vaccines, 13.","DOI":"10.3390\/vaccines13010092"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1215-2","article-title":"Targeting the CBM complex causes Treg cells to prime tumors for immune checkpoint therapy","volume":"570","author":"Kim","year":"2019","journal-title":"Nature"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"61","DOI":"10.36401\/JIPO-22-18","article-title":"Translational Studies Using the MALT1 Inhibitor (S)-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in Cancer","volume":"6","author":"Gao","year":"2023","journal-title":"J. Immunother. Precis. Oncol."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Mart\u00edn, E., Reina, G., and Carlos, S. (2025). Advances in Therapeutic Vaccines Against HPV: A Review of Human Clinical Trials. Curr. Oncol., 32.","DOI":"10.3390\/curroncol32110600"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1089\/hum.2017.197","article-title":"Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases","volume":"29","author":"Cheng","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41541-019-0129-1","article-title":"Successful application of prime and pull strategy for a therapeutic HSV vaccine","volume":"4","author":"Bernstein","year":"2019","journal-title":"npj Vaccines"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.4049\/jimmunol.1900462","article-title":"Cutting Edge: The Use of Topical Aminoglycosides as an Effective Pull in \u201cPrime and Pull\u201d Vaccine Strategy","volume":"204","author":"Gopinath","year":"2020","journal-title":"J. Immunol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature11522","article-title":"A vaccine strategy that protects against genital herpes by establishing local memory T cells","volume":"491","author":"Shin","year":"2012","journal-title":"Nature"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1186\/s12967-024-05703-9","article-title":"TCR-T cell therapy: Current development approaches, preclinical evaluation, and perspectives on regulatory challenges","volume":"22","author":"Golikova","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccell.2022.10.016","article-title":"Engineered T cell therapy for viral and non-viral epithelial cancers","volume":"41","author":"Norberg","year":"2023","journal-title":"Cancer Cell"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"e99488","DOI":"10.1172\/jci.insight.99488","article-title":"Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model","volume":"3","author":"Jin","year":"2018","journal-title":"JCI Insight"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41591-020-01225-1","article-title":"TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers","volume":"27","author":"Nagarsheth","year":"2021","journal-title":"Nat. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1200\/JCO.18.02424","article-title":"T-Cell Receptor Gene Therapy for Human Papillomavirus-Associated Epithelial Cancers: A First-in-Human, Phase I\/II Study","volume":"37","author":"Doran","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: Current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41571-024-00930-x","article-title":"Applications of cell therapy in the treatment of virus-associated cancers","volume":"21","author":"Toner","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41586-021-03862-z","article-title":"Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer","volume":"597","author":"Eberhardt","year":"2021","journal-title":"Nature"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): A randomised, double-blind, phase 3 clinical trial","volume":"403","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): A randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(25)00631-2","article-title":"Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303\/InterAACT-2): A global, phase 3 randomised controlled trial","volume":"405","author":"Rao","year":"2025","journal-title":"Lancet"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"BSR20203669","DOI":"10.1042\/BSR20203669","article-title":"PD-L1 expression in anogenital and oropharyngeal squamous cell carcinomas associated with different clinicopathological features, HPV status and prognosis: A meta-analysis","volume":"41","author":"Qin","year":"2021","journal-title":"Biosci. Rep."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Attia, J.V.D., Dessens, C.E., van de Water, R., Houvast, R.D., Kuppen, P.J.K., and Krijgsman, D. (2020). The molecular and functional characteristics of HLA-G and the interaction with its receptors: Where to intervene for cancer immunotherapy?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228678"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Carosella, E.D., Rouas-Freiss, N., Roux, D.T.L., Moreau, P., and LeMaoult, J. (2015). HLA-G: An Immune Checkpoint Molecule. Advances in Immunology, Academic Press.","DOI":"10.1016\/bs.ai.2015.04.001"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"e1077","DOI":"10.1002\/cti2.1077","article-title":"Intercellular transfer of HLA-G: Its potential in cancer immunology","volume":"8","author":"Lin","year":"2019","journal-title":"Clin. Transl. Immunol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/3\/362\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:37:53Z","timestamp":1773812273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/3\/362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":180,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["v18030362"],"URL":"https:\/\/doi.org\/10.3390\/v18030362","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]}}}